Venous Stents Patent Landscape Report 2026 Edition

The global venous stents market was valued at USD 1.19 Billion in 2025. It is expected to grow at a CAGR of 8.45% during the forecast period of 2026-2035 and attain a market value of USD 2.68 Billion by 2035. The market growth is driven by the increasing prevalence of chronic venous diseases. Patents are focused on advanced technologies such as iliac vein stent technology and wallstent technology.

Patent Landscape Report Coverage

The Global Venous Stents Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for venous stents include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with venous stents. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within venous stent technologies.

Key Inclusions:

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for venous stents technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Venous Stents.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for venous stents and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for venous stents and their relative value in the IP are covered in the final report.

What are Venous Stents?

Venous stents are tiny, expandable mesh tubes that are inserted into veins to open constricted or obstructed veins and restore normal blood flow. They are frequently used to treat ailments like chronic venous insufficiency (CVI) and deep vein thrombosis (DVT). Venous stents increase blood flow, reduce pain and swelling, and lower the chance of problems like venous ulcers.

The technologies of venous stents include iliac vein stent technology and wallstent technology. Iliac vein stent technology is a specialized technology intended to address blockages or narrowing in the iliac veins, which are vital blood vessels that transport blood from the legs to the heart. With this technology, stents have expandable mesh tubes that are implanted to restore normal blood flow and alleviate ailments like post-thrombotic syndrome, chronic venous insufficiency, and iliac vein compression syndrome. To ensure long-term patency and few complications, iliac vein stents are designed to be extremely flexible, strong, and resistant to compression. By lowering leg pain, swelling, and the risk of venous ulcers, these stents greatly enhance the quality of life for patients. Additionally, precise placement and integration with surrounding tissues are made easier by advanced designs.

Venous Stents Industry Growth Drivers

Advancements in Stent Design Technologies is Expected to Boost the Patent Industry Growth

The clinical use of venous stents has increased due to ongoing design advancements that have improved their flexibility, biocompatibility, and durability. The patent applications are also growing because of these advancements, which improve patient outcomes and lower complications, making stenting a more practical and efficient treatment option. For instance, an implantable medical device called the Duo Venous Stent System was introduced by Philips to treat symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency (CVI). The two stents in the Duo Venous Stent System called the Duo Hybrid and Duo Extend, were designed to meet the difficulties posed by venous anatomy and blockages.

There is an increase in patent activity which focuses on enhancing the performance of venous stents. In 2023, 956 patents were granted which increased to 1,055 by 2024. Patents covering these technologies are crucial for companies and thus impact the venous stent patent landscape.

Increasing Incidence of Venous Diseases is Expected to Propel Venous Stents Patent Industry

The need for venous stents is driven by the rising incidence of diseases like deep vein thrombosis and chronic venous insufficiency, which are frequently made worse by sedentary lifestyles and aging populations. Stenting procedures are required for these conditions to restore blood flow and relieve symptoms such as leg ulcers, pain, and swelling.

Venous Stents Patent Segmentation

The report will cover the following sections in detail:

Analysis by Technology

• Iliac Vein Stent Technology
• Wallstent Technology
• Others

Analysis by Indication

• Chronic Deep Vein Thrombosis
• Post-Thrombotic Syndrome (PTS)
• May-Thurner’s Syndrome
• Pelvic Congestion Syndrome (PCS)
• Others

Analysis by Application

• Leg
• Chest
• Abdomen
• Others

Venous Stents Patent Segmentation Analysis

The breakup based on technology includes iliac vein stent technology, wallstent technology, and others. Wallstent technology makes a particular kind of self-expanding stent that is used to treat vascular blockages, especially those that occur in the veins and arteries. These stents, which are composed of a flexible mesh material, provide structural support to maintain the blood vessel open by automatically expanding to the size of the vessel. Conditions like venous blockages, biliary obstructions, and coronary artery disease are frequently treated with wallstent technology.

Venous Stents Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for venous stent patents, having around 33,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with venous stents patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the venous stents field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Medtronic Inc.

It is a global leader in medical technology, headquartered in Dublin, Ireland, and founded in 1949. The company specializes in innovative healthcare solutions across cardiovascular, neurology, diabetes management, and surgical technologies. Medtronic has pioneered advancements like the Hugo™ Robotic-Assisted Surgery System, Micra™ leadless pacemaker, and AI-powered GI Genius™ diagnostic system. It holds numerous patents in deep brain stimulation, robotic surgery, and hybrid closed-loop insulin pumps, emphasizing AI, robotics, and minimally invasive care to improve patient outcomes.

Boston Scient Scimed Inc.

Headquartered in Marlborough, Massachusetts, and founded in 1979, it is a global leader in medical technology. The company specializes in innovative solutions for cardiovascular, neuromodulation, endoscopy, and urology. Key advancements include the SYNERGY™ bioabsorbable stent, WaveWriter Alpha™ SCS for pain management, and EXALT™ disposable duodenoscope to reduce infection risks. With patents in AI, robotics, and minimally invasive devices, Boston Scientific drives innovation to improve patient care worldwide.

Other companies include Edwards Lifesciences Corp, Cook Medical Technologies Llc, and Veniti Inc., among others.

Reasons to Purchase this Report

The venous stents patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of Venous Stents.
• Innovation Insights: The patent analysis reveals new innovations and technologies in Venous Stents.
• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the Venous Stents patent landscape.
• Risk Assessment: In technology-intensive fields such as venous stents, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Venous Stents Patent Landscape Report

• Who are the key players in the venous stents patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in venous stent patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the venous stents industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in venous stents?
• What are the challenges and opportunities in the venous stents patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in venous stents?